| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $215K | — | -81.8% |
| R&D Expense | $19.3M | — | +17.8% |
| SG&A Expense | $9.1M | — | -4.4% |
| Operating Income | -$30.8M | — | -11.2% |
| Pre-tax Income | -$29.6M | — | -12.3% |
| Income Tax | $18K | — | +550.0% |
| Net Income | -$29.6M | — | -12.3% |
| EPS (Basic) | -$0.19 | — | +9.5% |
| EPS (Diluted) | -$0.19 | — | +9.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.6M | -56.9% | -81.6% |
| Short-term Investments | $117.1M | -5.8% | — |
| Current Assets | $132.0M | -11.8% | -15.4% |
| Total Assets | $195.6M | -9.6% | -15.9% |
| Current Liabilities | $20.0M | -12.0% | -26.6% |
| Total Liabilities | $23.6M | -12.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$26.3M | — | -20.5% |
| Capital Expenditures | $30K | — | +20.0% |
| Investing Cash Flow | $7.4M | — | +148.9% |
| Financing Cash Flow | $7.6M | — | -82.3% |
| Free Cash Flow | -$26.3M | — | -20.5% |
| -29.8% |
| Stockholders' Equity | $172.0M | -9.2% | -13.5% |